Holen Sie sich die Stockscreener-App
2.40
1.05%
0.025
Handel nachbörslich:
2.38
-0.02
-0.83%
Schlusskurs vom Vortag:
$2.375
Offen:
$2.365
24-Stunden-Volumen:
8,293
Relative Volume:
0.08
Marktkapitalisierung:
$7.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.88M
KGV:
-2.6374
EPS:
-0.91
Netto-Cashflow:
$-19.93M
1W Leistung:
+2.56%
1M Leistung:
-10.45%
6M Leistung:
-47.71%
1J Leistung:
-67.55%
1-Tages-Spanne:
$2.3536
$2.4999
1-Wochen-Bereich:
$2.26
$2.4999
52-Wochen-Spanne:
$2.00
$13.95
Purple Biotech Ltd Adr Stock (PPBT) Company Profile
Firmenname
Purple Biotech Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PPBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPBT
Purple Biotech Ltd Adr
|
2.40 | 7.13M | 0 | -19.88M | -19.93M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Purple Biotech Ltd Adr Aktie (PPBT) Neueste Nachrichten
H.C. Wainwright lifts Purple Biotech stock target to $34 By Investing.com - Investing.com South Africa
Purple Biotech appoints Shai Lankry as new CFO By Investing.com - Investing.com South Africa
Purple Biotech appoints Shai Lankry as new CFO - Investing.com
PPG Industries, Inc [PPG] stock Downgrade by BofA Securities analyst, price target now $126 - dbtnews.com
Edison International [EIX] Is Currently -8.89 below its 200 Period Moving Avg: What Does This Mean? - dbtnews.com
Purple Biotech Ltd ADR [PPBT] moved down -5.16: Why It’s Important - dbtnews.com
Nextracker Inc (NXT) Stock: A Year of Market Fluctuations - investchronicle.com
RIO Stock: Exploring Rio Tinto plc ADR’s Growth - investchronicle.com
GoPro Inc Inc. (GPRO) Price Performance: A Technical Analysis Perspective - investchronicle.com
The Significance of Moving Averages in Purple Biotech Ltd ADR Inc. (PPBT) Price Performance - investchronicle.com
American Electric Power Company Inc (AEP) Stock: Navigating Drops and Gains - investchronicle.com
Today’s watch list includes Purple Biotech Ltd ADR (NASDAQ:PPBT) stock - uspostnews.com
Watch this stock’s price performance: Coty Inc (NYSE:COTY) - uspostnews.com
Danaher Corp: A Year of Highs, Lows, and Market Resilience - investchronicle.com
Udemy Inc (UDMY) deserves closer scrutiny - uspostnews.com
Do investors need to be concerned about FreightCar America Inc (RAIL)? - uspostnews.com
Post-Trade Analysis: Purple Biotech Ltd ADR (PPBT) Slides -1.85, Closing at 2.65 - DWinneX
Closing Bell Recap: WNS (Holdings) Limited (WNS) Ends at 59.25, Reflecting a -1.38 Downturn - DWinneX
UDR’s Stock Market Adventure: 0.46% YTD Growth Amidst Volatility - investchronicle.com
Okta Inc (OKTA) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial - GlobeNewswire Inc.
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy - Nasdaq
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.65% - MSN
PPBT stock touches 52-week low at $5.89 amid market challenges By Investing.com - Investing.com South Africa
What Makes Purple Biotech (PPBT) a New Buy Stock - Yahoo Finance
95 Promising Stocks You Can Currently Buy for Less Than $5 Per Share - GOBankingRates
Why Purple Biotech (PPBT) Shares Are Trading Lower - Benzinga
Here's Why Purple Biotech Ltd. Sponsored ADR (PPBT) Could be Great Choice for a Bottom Fisher - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance
Purple Biotech (PPBT) Stock Price, News & Analysis - MarketBeat
The FDA Just Approved Kitov's ConsensiNow What? (NASDAQ:PPBT) - Seeking Alpha
Finanzdaten der Purple Biotech Ltd Adr-Aktie (PPBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):